BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

37 Suppliers, 20 USDMF, 16 CEP/COS, 2 JDMF, 6 EU WC, 26 NDC API, 21 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

6 Suppliers

6 Suppliers

DOSSIERs // Finished Dosage Forms

172 Dossiers, 99 FDA Orange Book, 33 Europe, 22 Canada, 4 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 0.3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, IMPLANT;IMPLANTATION - EQ 80MG BASE/IMPLANT, FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE, FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE, FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE, TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM;BUCCAL - EQ 0.075MG BASE, FILM;BUCCAL - EQ 0.15MG BASE, FILM;BUCCAL - EQ 0.3MG BASE, FILM;BUCCAL - EQ 0.45MG BASE, FILM;BUCCAL - EQ 0.6MG BASE, FILM;BUCCAL - EQ 0.75MG BASE, FILM;BUCCAL - EQ 0.9MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 37 Kerry, 26 Roquette, 23 BASF, 19 Microlex e.U, 17 SPI Pharma, 13 Gangwal Healthcare, 11 Actylis, 10 Sigachi Industries, 10 Corel Pharma Chem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Chemicals, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Rochem International Inc, 6 DFE Pharma, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 5 DKSH, 4 Kima Chemical, 4 Prachin Chemical, 4 Pharmatrans-Sanaq, 4 Ingredion Pharma Solutions, 3 Ulanqab Kema New Material, 3 The Dow Chemical Company, 3 Finar, 3 Vasa Pharmachem, 3 Nanjing Well Pharmaceutical, 2 Seqens, 2 Nippon Fine Chemical, 2 Jai Radhe Sales, 2 Pfanstiehl, 2 Alcedo Pharmachem, 2 Nomisma Healthcare, 1 Zhejiang Huakang Pharmaceutical, 1 Lubrizol Life Science Health, 1 Minakem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Bioplus Life Sciences, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Shanghai Welltone Material Technology Co., Ltd, 1 NEWEDGE Overseas, 1 Pharm-RX Chemical, 1 Chynops Pharma, 1 Valens Pharmachem, 1 ACG Worldwide, 1 Qualicaps

EXCIPIENTS BY APPLICATIONS

90 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 41 Direct Compression, 35 Disintegrants & Superdisintegrants, 34 Thickeners and Stabilizers, 30 Controlled & Modified Release, 26 Granulation, 26 Taste Masking, 22 Solubilizers, 20 Chewable & Orodispersible Aids, 18 Co-Processed Excipients, 18 Lubricants & Glidants, 15 Parenteral, 13 Film Formers & Plasticizers, 13 Topical, 6 API Stability Enhancers, 6 Emulsifying Agents, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 4 Finished Drug Prices

MARKET PLACE

8 APIs, 4 DOSSIERS // FDF

PATENTS

102 US Patents

102 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 4 Others

DIGITAL CONTENT

54 News

54 News

Manufacturers & Suppliers of BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

37 Suppliers

20 USDMF

16 CEP/COS

2 JDMF

6 EU WC

26 NDC API

21 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

6 Suppliers

DOSSIERs // Finished Dosage Forms

172 Dossiers

99 FDA Orange Book

33 Europe

22 Canada

4 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 0.3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

IMPLANT;IMPLANTATION - EQ 80MG BASE/IMPLANT

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE

FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE

FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE

TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM;BUCCAL - EQ 0.075MG BASE

FILM;BUCCAL - EQ 0.15MG BASE

FILM;BUCCAL - EQ 0.3MG BASE

FILM;BUCCAL - EQ 0.45MG BASE

FILM;BUCCAL - EQ 0.6MG BASE

FILM;BUCCAL - EQ 0.75MG BASE

FILM;BUCCAL - EQ 0.9MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

37 Kerry

26 Roquette

23 BASF

19 Microlex e.U

17 SPI Pharma

13 Gangwal Healthcare

11 Actylis

10 Sigachi Industries

10 Corel Pharma Chem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 Boai NKY Pharmaceuticals Ltd

8 Gangwal Chemicals

7 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Rochem International Inc

6 DFE Pharma

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

5 DKSH

4 Kima Chemical

4 Prachin Chemical

4 Pharmatrans-Sanaq

4 Ingredion Pharma Solutions

3 Ulanqab Kema New Material

3 The Dow Chemical Company

3 Finar

3 Vasa Pharmachem

3 Nanjing Well Pharmaceutical

2 Seqens

2 Nippon Fine Chemical

2 Jai Radhe Sales

INJECTABLE;INJECTION - EQ 0.3MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons